Novavax (NVAX) Other Operating Expenses (2011 - 2026)
Novavax (NVAX) recorded Other Operating Expenses of $14.25 million in Q2 2026, down 7.0% from $15.33 million a year earlier and down 53.6% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Other Operating Expenses (2011 - 2026) Analysis & Trends
On a TTM basis, Novavax's Other Operating Expenses came in at $186.39 million as of Jun 30, 2026, up 47.1% year-over-year; for FY2025, it was $170.89 million, down 15.7% from FY2024.
- Annual Other Operating Expenses has declined for three straight years, with a three-year compound annual growth rate of -42.6% (FY2022 to FY2025).
- Across earlier years, Other Operating Expenses came in at $202.74 million in FY2024 (-41.0%), $343.77 million in FY2023 (-61.9%) and $902.64 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Other Operating Expenses since Q1 2025.
- On a year-over-year basis, Other Operating Expenses rose in two of the last eight quarters, with an average decline of 11.2%.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 124.2% in Q1 2023, against a decline of 79.4% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $30.7 million (Q1 2026), $22.91 million (Q4 2025) and $118.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.49 Mn |
| Jun 30, 2026 | 14.25 Mn |
| Mar 31, 2026 | 30.70 Mn |
| Dec 31, 2025 | 22.91 Mn |
| Sep 30, 2025 | 118.53 Mn |
| Jun 30, 2025 | 15.33 Mn |
| Mar 31, 2025 | 14.12 Mn |
| Dec 31, 2024 | 36.67 Mn |
| Sep 30, 2024 | 60.62 Mn |
| Jun 30, 2024 | 46.24 Mn |
| Mar 31, 2024 | 59.21 Mn |
| Dec 31, 2023 | 154.98 Mn |
| Sep 30, 2023 | 98.93 Mn |
| Jun 30, 2023 | 55.78 Mn |
| Mar 31, 2023 | 34.09 Mn |
| Dec 31, 2022 | 181.77 Mn |
| Sep 30, 2022 | 434.59 Mn |
| Jun 30, 2022 | 271.08 Mn |
| Mar 31, 2022 | 15.20 Mn |
| Sep 30, 2019 | 9.02 Mn |
API Access
Novavax Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();